Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Cagrilintide/semaglutide

REDEFINE

Novo Nordisk · Phase 3 · Not yet recruiting · Enrollment 1408

NCT07919405

ArmPopulationDoseWeeksEstimandWeight change
CagriSemaObesity or overweightn/rn/rn/rn/r
SemaglutideObesity or overweightn/rn/rn/rn/r
CagrilintideObesity or overweightn/rn/rn/rn/r
PlaceboObesity or overweightn/rn/rn/rn/r